Takeda Pharmaceutical Co Ltd ADR (TAK) — Cash Flow Reinvestment Rate
Takeda Pharmaceutical Co Ltd ADR (TAK) has a Cash Flow Reinvestment Rate of 0.16x as of December 2025, reinvesting $55.93 Billion (capex $42.57 Billion plus investments $-13.37 Billion) from operating cash flow of $360.04 Billion. Explore capital reinvestment ratio of Takeda Pharmaceutical Co Ltd ADR to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Takeda Pharmaceutical Co Ltd ADR Cash Flow Reinvestment Rate (2000–2025)
Historical reinvestment intensity for Takeda Pharmaceutical Co Ltd ADR across 26 annual periods. Also explore TAK asset base for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Takeda Pharmaceutical Co Ltd ADR (2000–2025)
Year-by-year capital reinvestment analysis for Takeda Pharmaceutical Co Ltd ADR. For live market cap and broader valuation context, see TAK market cap overview.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.54x | $567.86 Billion | $1.06 Trillion | $200.79 Billion | ▼ -59.3% |
| 2024 | 1.32x | $944.59 Billion | $716.34 Billion | $480.73 Billion | ▲ +3.8% |
| 2023 | 1.27x | $1.24 Trillion | $977.16 Billion | $633.69 Billion | ▲ +271.2% |
| 2022 | 0.34x | $384.16 Billion | $1.12 Trillion | $186.04 Billion | ▲ +15.9% |
| 2021 | 0.30x | $298.48 Billion | $1.01 Trillion | $236.47 Billion | ▼ -61.2% |
| 2020 | 0.76x | $509.83 Billion | $669.75 Billion | $217.71 Billion | ▼ -91.6% |
| 2019 | 9.04x | $2.97 Trillion | $328.48 Billion | $134.11 Billion | ▲ +1441.6% |
| 2018 | 0.59x | $221.60 Billion | $377.85 Billion | $128.26 Billion | ▼ -80.0% |
| 2017 | 2.94x | $767.72 Billion | $261.36 Billion | $112.03 Billion | ▼ -11.8% |
| 2016 | 3.33x | $84.86 Billion | $25.49 Billion | $84.86 Billion | ▲ +452.0% |
| 2015 | 0.60x | $110.06 Billion | $182.52 Billion | $108.72 Billion | ▲ +13.9% |
| 2014 | 0.53x | $78.52 Billion | $148.34 Billion | $78.52 Billion | ▲ +70.1% |
| 2013 | 0.31x | $95.76 Billion | $307.71 Billion | $95.76 Billion | ▲ +69.2% |
| 2012 | 0.18x | $61.90 Billion | $336.57 Billion | $61.90 Billion | ▼ -51.6% |
| 2011 | 0.38x | $124.17 Billion | $326.94 Billion | $124.17 Billion | ▲ +66.5% |
| 2010 | 0.23x | $86.96 Billion | $381.17 Billion | $86.96 Billion | ▲ +88.6% |
| 2009 | 0.12x | $39.46 Billion | $326.27 Billion | $39.46 Billion | ▲ +8.5% |
| 2008 | 0.11x | $32.62 Billion | $292.50 Billion | $32.62 Billion | ▼ -19.9% |
| 2007 | 0.14x | $29.15 Billion | $209.28 Billion | $29.15 Billion | ▲ +62.1% |
| 2006 | 0.09x | $32.09 Billion | $373.57 Billion | $32.09 Billion | ▼ -52.7% |
| 2005 | 0.18x | $53.67 Billion | $295.54 Billion | $53.67 Billion | ▲ +4.3% |
| 2004 | 0.17x | $54.16 Billion | $311.12 Billion | $54.16 Billion | ▲ +37.0% |
| 2003 | 0.13x | $33.48 Billion | $263.45 Billion | $33.48 Billion | ▼ -18.5% |
| 2002 | 0.16x | $37.52 Billion | $240.59 Billion | $37.52 Billion | ▲ +23.1% |
| 2001 | 0.13x | $26.94 Billion | $212.66 Billion | $26.94 Billion | ▼ -43.1% |
| 2000 | 0.22x | $35.42 Billion | $158.96 Billion | $35.42 Billion | — |